Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Real-world study of GnRHa combined with recombinant human growth hormone in girls with central precocious puberty or rapidly progressive puberty
ChiCTR1800016768Phase 4Recruiting
- Sponsor
- Children's Hospital, Zhejiang University School of Medicine
- Start
- Jun 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of gonadotropin-releasing hormone agonist and somatropin in central precocious puberty (CPP) and precocious puberty, sponsored by Children's Hospital, Zhejiang University School of Medicine. Primary endpoints: Predicted adult height change and Actual height change. Started Jun 2018; status: recruiting.
02
Drugs
gonadotropin-releasing hormone agonistsomatropin
03
Conditions
central precocious puberty (CPP)precocious puberty
Beyond the preview
Go deeper on ChiCTR1800016768.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800016768.